Thousands tracked to see how a Drug-Coated stent performs in daily use
NCT ID NCT05505929
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This registry is following 10,000 people who receive the BioFreedom Ultra stent, a device coated with the drug biolimus A9 to keep heart arteries open. The goal is to see how well the stent works in real-world patients, not just in controlled trials. Researchers will track problems like the need for repeat procedures, heart attacks, or stent blockages over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Biolimus A9-coated coronary stent
What this could lead to
If successful, this registry will confirm that the BioFreedom Ultra stent works safely in everyday patients, supporting its continued use for coronary artery disease.
What could go wrong
This is an observational registry, not a controlled trial, so results may be influenced by patient differences. It does not test a new treatment, only monitors existing practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Al Qassimi Hospital
RECRUITINGSharjah city, United Arab Emirates
Contact
-
Clinique Des Domes Psr
RECRUITINGClermont-Ferrand, France
Contact
-
Golden Jubilee National Hospital
RECRUITINGGlasgow, United Kingdom
Contact
-
Hospital Marques Valdecilla
RECRUITINGSantander, Spain
Contact
-
Klinikum Lippe
RECRUITINGDetmold, Germany
Contact
-
Krankenhaus Barmherzige Brüder
RECRUITINGEisenstadt, Austria
Contact
-
Military hospital
RECRUITINGTunis, Tunisia
Contact
-
Royal Bournemouth hospital
RECRUITINGBournemouth, United Kingdom
Contact
-
University and Hospital Fribourg
RECRUITINGFribourg, Switzerland
Contact
-
Universitäres Herzzentrum
RECRUITINGZurich, Switzerland
Contact